Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
Nature Communications
Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI | Nature Medicine
Journal Metrics | Nature Portfolio
Nature Medicine
Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021 | Nature Communications
Long COVID in a prospective cohort of home-isolated patients | Nature Medicine
AI in health and medicine | Nature Medicine
Genetics in Medicine
A guide to immunotherapy for COVID-19 | Nature Medicine
Modeling transmission of SARS-CoV-2 Omicron in China | Nature Medicine
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results | Nature Medicine
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma | Nature Medicine
Nature Medicine
Nature (journal) - Wikipedia
Journal Metrics | Nature Medicine
Volume 25 | Nature Medicine
A survey of COVID-19 vaccine acceptance across 23 countries in 2022 | Nature Medicine
Multimodal biomedical AI | Nature Medicine
Open access at the Nature Portfolio | Nature Portfolio
Open access: The true cost of science publishing | Nature
npj Genomic Medicine
Nature Medicine (@NatureMedicine) / Twitter
Nature journals reveal terms of landmark open-access option
Molecular Medicine | Home
